Exploring Japan's High Growth Tech Stocks for September 2024

In This Article:

As Japan's stock markets show mixed performance, with the Nikkei 225 Index gaining 0.5% and the broader TOPIX Index down 1.0%, investors are keenly observing how economic indicators and monetary policy shifts will impact high-growth sectors such as technology. In this environment, identifying promising tech stocks involves looking for companies that exhibit strong innovation capabilities, robust financial health, and resilience to currency fluctuations.

Top 10 High Growth Tech Companies In Japan

Name

Revenue Growth

Earnings Growth

Growth Rating

Hottolink

50.99%

61.55%

★★★★★★

Medley

24.98%

30.36%

★★★★★★

eWeLLLtd

26.52%

27.53%

★★★★★★

f-code

22.70%

22.62%

★★★★★☆

Material Group

17.82%

28.74%

★★★★★☆

GMO AD Partners

69.79%

97.87%

★★★★★☆

Kanamic NetworkLTD

20.75%

28.25%

★★★★★★

Bengo4.comInc

20.76%

46.76%

★★★★★★

ExaWizards

21.96%

75.16%

★★★★★★

Money Forward

20.68%

68.12%

★★★★★★

Click here to see the full list of 125 stocks from our Japanese High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

GNI Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally with a market cap of ¥124.90 billion.

Operations: GNI Group Ltd. generates revenue primarily from its pharmaceutical segment, which accounted for ¥19.35 billion, and its medical device segment, contributing ¥4.30 billion. The company focuses on the development and sale of pharmaceutical drugs both domestically and internationally.

GNI Group's revenue is forecast to grow at an impressive 24.6% annually, outpacing the Japanese market's 4.3%. The company has seen a remarkable earnings growth of 393.9% over the past year, significantly higher than the Biotech industry’s 172.6%. Recent approval for Avatrombopag Maleate Tablets adds a third product to their lineup, enhancing their position in rare disease treatments. With R&D expenses contributing to this innovation drive, GNI's future looks promising with projected annual earnings growth of 18.9%.

TSE:2160 Revenue and Expenses Breakdown as at Sep 2024
TSE:2160 Revenue and Expenses Breakdown as at Sep 2024

Kakaku.com

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Kakaku.com, Inc., along with its subsidiaries, offers purchase support and restaurant review services in Japan and has a market cap of ¥505.48 billion.

Operations: Kakaku.com, Inc. generates revenue primarily through its purchase support and restaurant review services in Japan. The company's market cap stands at ¥505.48 billion.